Desmidt Paul gastro-enterologie - Rosier Joëlle algemene geneeskunde
0838.483.044 · rovalta.com · 28/09/2026
NORMAL SITUATION
Desmidt Paul gastro-enterologie - Rosier Joëlle algemene geneeskunde
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result20,1 k €-87,9 %over 1 year
Gross margin36,6 k €-85,4 %over 1 year
Equity1 M €+2,0 %over 1 year
Overview
Identity
Source · BCE/KBODesmidt Paul gastro-enterologie - Rosier Joëlle algemene geneeskunde is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0838.483.044
- Legal form
- Private company with limited liability
- Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2022
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 36,6 k € | -85.4% | 250,6 k € | +43.0% | 175,2 k € | -17.8% | 213 k € | +17.2% | 181,8 k € |
| EBITDA | 33,8 k € | -86.4% | 248,3 k € | +43.9% | 172,6 k € | -18.1% | 210,8 k € | +17.0% | 180,1 k € |
| Operating result | 31,3 k € | -87.1% | 242,8 k € | +44.4% | 168,2 k € | -14.8% | 197,5 k € | +18.4% | 166,8 k € |
| Net result | 20,1 k € | -87.9% | 166,6 k € | +41.4% | 117,8 k € | -12.8% | 135,2 k € | +29.6% | 104,3 k € |
| Balance sheet | |||||||||
| Equity | 1 M € | +2.0% | 1 M € | +19.8% | 843,1 k € | +16.2% | 725,3 k € | +22.9% | 590,1 k € |
| Total assets | 1 M € | -1.0% | 1 M € | +20.4% | 869,4 k € | +14.7% | 757,7 k € | +25.7% | 603 k € |
| Cash | 934,7 k € | -0.4% | 938,6 k € | +24.9% | 751,2 k € | +16.3% | 646,2 k € | +43.1% | 451,5 k € |
| Debts | 2,2 k € | -93.9% | 36,6 k € | +42.6% | 25,6 k € | -19.5% | 31,8 k € | +159% | 12,3 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20222 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Joëlle Rosier | DirectorManagerended | |
Paul Desmidt | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/05/2023 | 24/08/2022 | 31/08/2021 | 28/08/2020 | 27/08/2019 | 31/08/2018 |
| General meeting | 16/05/2023 | 01/06/2022 | 02/06/2021 | 03/06/2020 | 05/06/2019 | 06/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2022 | 16/05/2023 | 31/05/2023 | Dutch | |
| Micro model | 31/12/2021 | 01/06/2022 | 24/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 02/06/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 03/06/2020 | 28/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 05/06/2019 | 27/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 06/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 07/06/2017 | 23/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 30/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 03/06/2015 | 14/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 04/06/2014 | 22/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 05/06/2013 | 26/08/2013 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20222 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Joëlle Rosier | DirectorManagerended | |
Paul Desmidt | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings11 filings
201220132014201520162017201820192020202120222023202420252026
Desmidt Paul gastro-enterologie - Rosier Joëlle al
Kruisstraat 42, 9570 Lierde
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Kruisstraat 42, 9570 Lierde | accounts 2021 → 2022 | Accounts 2022 · 2023-00099425 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Desmidt Paul gastro-enterologie - Rosier Joëlle al | accounts 2021 → 2022 | Accounts 2022 · 2023-00099425 |
Events
- 2022Annual accounts 202220,1 k €↓
- 2021Annual accounts 2021166,6 k €↑
- 2020Annual accounts 2020117,8 k €↓
- 2019Annual accounts 2019135,2 k €↑
- 2018Annual accounts 2018104,3 k €↑
- 2017Annual accounts 201799,4 k €↑
- 2016Annual accounts 201682,8 k €↓
- 2015Annual accounts 201588,7 k €↓
- 2014Annual accounts 2014106,2 k €↑
- 2013Annual accounts 201399,1 k €↓
- 2012Annual accounts 2012168,4 k €